The Molecular Targets of Swertiamarin and its Derivatives Confer Anti-Diabetic and Anti-Hyperlipidemic Effects. (Q52603113)
Jump to navigation
Jump to search
scientific article published on 5 April 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | The Molecular Targets of Swertiamarin and its Derivatives Confer Anti-Diabetic and Anti-Hyperlipidemic Effects. |
scientific article published on 5 April 2018 |
Statements
The Molecular Targets of Swertiamarin and its Derivatives Confer Anti-Diabetic and Anti-Hyperlipidemic Effects. (English)
Naisargee Patel
Rajeev Kumar Tyagi
Nikunj Tandel
Neeraj Garg
Nupur Soni
5 April 2018